nodes	percent_of_prediction	percent_of_DWPC	metapath
Propericiazine—Ethopropazine—BCHE—peripheral nervous system neoplasm	0.00479	0.241	CrCbGaD
Propericiazine—Jaundice—Melphalan—peripheral nervous system neoplasm	0.00466	0.00476	CcSEcCtD
Propericiazine—Agranulocytosis—Tretinoin—peripheral nervous system neoplasm	0.00452	0.00462	CcSEcCtD
Propericiazine—Agranulocytosis—Isotretinoin—peripheral nervous system neoplasm	0.00452	0.00462	CcSEcCtD
Propericiazine—Nasal congestion—Cisplatin—peripheral nervous system neoplasm	0.00446	0.00455	CcSEcCtD
Propericiazine—Asthma—Alitretinoin—peripheral nervous system neoplasm	0.00412	0.0042	CcSEcCtD
Propericiazine—Sweating increased—Alitretinoin—peripheral nervous system neoplasm	0.00401	0.0041	CcSEcCtD
Propericiazine—Pneumonia—Dactinomycin—peripheral nervous system neoplasm	0.00399	0.00407	CcSEcCtD
Propericiazine—Triflupromazine—BCHE—peripheral nervous system neoplasm	0.00392	0.198	CrCbGaD
Propericiazine—Arrhythmia—Tretinoin—peripheral nervous system neoplasm	0.00389	0.00397	CcSEcCtD
Propericiazine—Arrhythmia—Isotretinoin—peripheral nervous system neoplasm	0.00389	0.00397	CcSEcCtD
Propericiazine—Arrhythmia—Melphalan—peripheral nervous system neoplasm	0.00384	0.00392	CcSEcCtD
Propericiazine—Photosensitivity reaction—Alitretinoin—peripheral nervous system neoplasm	0.00376	0.00384	CcSEcCtD
Propericiazine—Weight increased—Alitretinoin—peripheral nervous system neoplasm	0.00375	0.00383	CcSEcCtD
Propericiazine—Agranulocytosis—Dactinomycin—peripheral nervous system neoplasm	0.0037	0.00377	CcSEcCtD
Propericiazine—Hypokalaemia—Cisplatin—peripheral nervous system neoplasm	0.0037	0.00377	CcSEcCtD
Propericiazine—Pneumonia—Alitretinoin—peripheral nervous system neoplasm	0.0037	0.00377	CcSEcCtD
Propericiazine—Drowsiness—Alitretinoin—peripheral nervous system neoplasm	0.00367	0.00375	CcSEcCtD
Propericiazine—Erectile dysfunction—Vincristine—peripheral nervous system neoplasm	0.00366	0.00373	CcSEcCtD
Propericiazine—Photosensitivity reaction—Vincristine—peripheral nervous system neoplasm	0.00362	0.0037	CcSEcCtD
Propericiazine—Vision blurred—Tretinoin—peripheral nervous system neoplasm	0.00357	0.00364	CcSEcCtD
Propericiazine—Vision blurred—Isotretinoin—peripheral nervous system neoplasm	0.00357	0.00364	CcSEcCtD
Propericiazine—Pneumonia—Vincristine—peripheral nervous system neoplasm	0.00356	0.00363	CcSEcCtD
Propericiazine—Tremor—Tretinoin—peripheral nervous system neoplasm	0.00355	0.00362	CcSEcCtD
Propericiazine—Tremor—Isotretinoin—peripheral nervous system neoplasm	0.00355	0.00362	CcSEcCtD
Propericiazine—Angioedema—Topotecan—peripheral nervous system neoplasm	0.00349	0.00356	CcSEcCtD
Propericiazine—Agitation—Tretinoin—peripheral nervous system neoplasm	0.00348	0.00355	CcSEcCtD
Propericiazine—Agitation—Isotretinoin—peripheral nervous system neoplasm	0.00348	0.00355	CcSEcCtD
Propericiazine—Agranulocytosis—Alitretinoin—peripheral nervous system neoplasm	0.00343	0.0035	CcSEcCtD
Propericiazine—Sweating increased—Cisplatin—peripheral nervous system neoplasm	0.00342	0.00349	CcSEcCtD
Propericiazine—Liver injury—Epirubicin—peripheral nervous system neoplasm	0.00342	0.00348	CcSEcCtD
Propericiazine—Jaundice cholestatic—Epirubicin—peripheral nervous system neoplasm	0.00327	0.00334	CcSEcCtD
Propericiazine—Amenorrhoea—Epirubicin—peripheral nervous system neoplasm	0.00327	0.00334	CcSEcCtD
Propericiazine—Liver injury—Doxorubicin—peripheral nervous system neoplasm	0.00316	0.00322	CcSEcCtD
Propericiazine—Dry mouth—Tretinoin—peripheral nervous system neoplasm	0.00315	0.00322	CcSEcCtD
Propericiazine—Dry mouth—Isotretinoin—peripheral nervous system neoplasm	0.00315	0.00322	CcSEcCtD
Propericiazine—Sweating increased—Etoposide—peripheral nervous system neoplasm	0.00313	0.0032	CcSEcCtD
Propericiazine—Confusional state—Tretinoin—peripheral nervous system neoplasm	0.00312	0.00318	CcSEcCtD
Propericiazine—Confusional state—Isotretinoin—peripheral nervous system neoplasm	0.00312	0.00318	CcSEcCtD
Propericiazine—Infection—Topotecan—peripheral nervous system neoplasm	0.0031	0.00316	CcSEcCtD
Propericiazine—Oedema—Tretinoin—peripheral nervous system neoplasm	0.00309	0.00315	CcSEcCtD
Propericiazine—Oedema—Isotretinoin—peripheral nervous system neoplasm	0.00309	0.00315	CcSEcCtD
Propericiazine—Infection—Tretinoin—peripheral nervous system neoplasm	0.00307	0.00313	CcSEcCtD
Propericiazine—Infection—Isotretinoin—peripheral nervous system neoplasm	0.00307	0.00313	CcSEcCtD
Propericiazine—Dyskinesia—Epirubicin—peripheral nervous system neoplasm	0.00306	0.00312	CcSEcCtD
Propericiazine—Oedema—Melphalan—peripheral nervous system neoplasm	0.00305	0.00311	CcSEcCtD
Propericiazine—Infection—Melphalan—peripheral nervous system neoplasm	0.00303	0.00309	CcSEcCtD
Propericiazine—Amenorrhoea—Doxorubicin—peripheral nervous system neoplasm	0.00303	0.00309	CcSEcCtD
Propericiazine—Jaundice cholestatic—Doxorubicin—peripheral nervous system neoplasm	0.00303	0.00309	CcSEcCtD
Propericiazine—Tachycardia—Tretinoin—peripheral nervous system neoplasm	0.00302	0.00308	CcSEcCtD
Propericiazine—Tachycardia—Isotretinoin—peripheral nervous system neoplasm	0.00302	0.00308	CcSEcCtD
Propericiazine—Hyperhidrosis—Topotecan—peripheral nervous system neoplasm	0.00301	0.00307	CcSEcCtD
Propericiazine—Hyperhidrosis—Tretinoin—peripheral nervous system neoplasm	0.00299	0.00305	CcSEcCtD
Propericiazine—Hyperhidrosis—Isotretinoin—peripheral nervous system neoplasm	0.00299	0.00305	CcSEcCtD
Propericiazine—Tachycardia—Melphalan—peripheral nervous system neoplasm	0.00298	0.00304	CcSEcCtD
Propericiazine—Atrioventricular block—Epirubicin—peripheral nervous system neoplasm	0.00296	0.00302	CcSEcCtD
Propericiazine—Cardiac disorder—Vincristine—peripheral nervous system neoplasm	0.00295	0.00301	CcSEcCtD
Propericiazine—Arrhythmia—Alitretinoin—peripheral nervous system neoplasm	0.00295	0.00301	CcSEcCtD
Propericiazine—Hypotension—Tretinoin—peripheral nervous system neoplasm	0.00289	0.00295	CcSEcCtD
Propericiazine—Hypotension—Isotretinoin—peripheral nervous system neoplasm	0.00289	0.00295	CcSEcCtD
Propericiazine—Pneumonia—Etoposide—peripheral nervous system neoplasm	0.00288	0.00294	CcSEcCtD
Propericiazine—Pulmonary embolism—Epirubicin—peripheral nervous system neoplasm	0.00287	0.00293	CcSEcCtD
Propericiazine—Ventricular tachycardia—Epirubicin—peripheral nervous system neoplasm	0.00287	0.00293	CcSEcCtD
Propericiazine—Hypotension—Melphalan—peripheral nervous system neoplasm	0.00285	0.00291	CcSEcCtD
Propericiazine—Dyskinesia—Doxorubicin—peripheral nervous system neoplasm	0.00283	0.00289	CcSEcCtD
Propericiazine—Insomnia—Tretinoin—peripheral nervous system neoplasm	0.0028	0.00285	CcSEcCtD
Propericiazine—Insomnia—Isotretinoin—peripheral nervous system neoplasm	0.0028	0.00285	CcSEcCtD
Propericiazine—Jaundice—Etoposide—peripheral nervous system neoplasm	0.0028	0.00285	CcSEcCtD
Propericiazine—Dyspnoea—Topotecan—peripheral nervous system neoplasm	0.00278	0.00284	CcSEcCtD
Propericiazine—Dyspnoea—Isotretinoin—peripheral nervous system neoplasm	0.00276	0.00281	CcSEcCtD
Propericiazine—Dyspnoea—Tretinoin—peripheral nervous system neoplasm	0.00276	0.00281	CcSEcCtD
Propericiazine—Somnolence—Isotretinoin—peripheral nervous system neoplasm	0.00275	0.0028	CcSEcCtD
Propericiazine—Somnolence—Tretinoin—peripheral nervous system neoplasm	0.00275	0.0028	CcSEcCtD
Propericiazine—Atrioventricular block—Doxorubicin—peripheral nervous system neoplasm	0.00274	0.0028	CcSEcCtD
Propericiazine—Dyspnoea—Melphalan—peripheral nervous system neoplasm	0.00272	0.00278	CcSEcCtD
Propericiazine—Vision blurred—Alitretinoin—peripheral nervous system neoplasm	0.00271	0.00276	CcSEcCtD
Propericiazine—Tremor—Alitretinoin—peripheral nervous system neoplasm	0.00269	0.00274	CcSEcCtD
Propericiazine—Agranulocytosis—Etoposide—peripheral nervous system neoplasm	0.00268	0.00273	CcSEcCtD
Propericiazine—Constipation—Topotecan—peripheral nervous system neoplasm	0.00267	0.00272	CcSEcCtD
Propericiazine—Pulmonary embolism—Doxorubicin—peripheral nervous system neoplasm	0.00266	0.00271	CcSEcCtD
Propericiazine—Ventricular tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.00266	0.00271	CcSEcCtD
Propericiazine—Constipation—Isotretinoin—peripheral nervous system neoplasm	0.00264	0.0027	CcSEcCtD
Propericiazine—Constipation—Tretinoin—peripheral nervous system neoplasm	0.00264	0.0027	CcSEcCtD
Propericiazine—Agitation—Alitretinoin—peripheral nervous system neoplasm	0.00264	0.00269	CcSEcCtD
Propericiazine—Cardiac disorder—Cisplatin—peripheral nervous system neoplasm	0.00261	0.00266	CcSEcCtD
Propericiazine—Agitation—Vincristine—peripheral nervous system neoplasm	0.00254	0.00259	CcSEcCtD
Propericiazine—Oedema—Dactinomycin—peripheral nervous system neoplasm	0.00253	0.00258	CcSEcCtD
Propericiazine—Infection—Dactinomycin—peripheral nervous system neoplasm	0.00251	0.00256	CcSEcCtD
Propericiazine—Arrhythmia—Cisplatin—peripheral nervous system neoplasm	0.00251	0.00256	CcSEcCtD
Propericiazine—Body temperature increased—Topotecan—peripheral nervous system neoplasm	0.00246	0.00251	CcSEcCtD
Propericiazine—Body temperature increased—Tretinoin—peripheral nervous system neoplasm	0.00244	0.00249	CcSEcCtD
Propericiazine—Body temperature increased—Isotretinoin—peripheral nervous system neoplasm	0.00244	0.00249	CcSEcCtD
Propericiazine—Dry mouth—Alitretinoin—peripheral nervous system neoplasm	0.00239	0.00244	CcSEcCtD
Propericiazine—Cardiac disorder—Etoposide—peripheral nervous system neoplasm	0.00239	0.00244	CcSEcCtD
Propericiazine—Photosensitivity—Epirubicin—peripheral nervous system neoplasm	0.00238	0.00242	CcSEcCtD
Propericiazine—Confusional state—Alitretinoin—peripheral nervous system neoplasm	0.00236	0.00241	CcSEcCtD
Propericiazine—Oedema—Alitretinoin—peripheral nervous system neoplasm	0.00234	0.00239	CcSEcCtD
Propericiazine—Infection—Alitretinoin—peripheral nervous system neoplasm	0.00233	0.00238	CcSEcCtD
Propericiazine—Vision blurred—Cisplatin—peripheral nervous system neoplasm	0.00231	0.00235	CcSEcCtD
Propericiazine—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.0023	0.00234	CcSEcCtD
Propericiazine—Tremor—Cisplatin—peripheral nervous system neoplasm	0.00229	0.00234	CcSEcCtD
Propericiazine—Tachycardia—Alitretinoin—peripheral nervous system neoplasm	0.00229	0.00233	CcSEcCtD
Propericiazine—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.00228	0.00232	CcSEcCtD
Propericiazine—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.00228	0.00232	CcSEcCtD
Propericiazine—Hyperhidrosis—Alitretinoin—peripheral nervous system neoplasm	0.00227	0.00231	CcSEcCtD
Propericiazine—Oedema—Vincristine—peripheral nervous system neoplasm	0.00226	0.0023	CcSEcCtD
Propericiazine—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.00225	0.00229	CcSEcCtD
Propericiazine—Infection—Vincristine—peripheral nervous system neoplasm	0.00224	0.00229	CcSEcCtD
Propericiazine—Increased appetite—Epirubicin—peripheral nervous system neoplasm	0.00222	0.00227	CcSEcCtD
Propericiazine—Photosensitivity—Doxorubicin—peripheral nervous system neoplasm	0.0022	0.00224	CcSEcCtD
Propericiazine—Hypotension—Alitretinoin—peripheral nervous system neoplasm	0.00219	0.00223	CcSEcCtD
Propericiazine—Hyperhidrosis—Vincristine—peripheral nervous system neoplasm	0.00218	0.00223	CcSEcCtD
Propericiazine—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.00213	0.00218	CcSEcCtD
Propericiazine—Insomnia—Alitretinoin—peripheral nervous system neoplasm	0.00212	0.00216	CcSEcCtD
Propericiazine—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.00212	0.00216	CcSEcCtD
Propericiazine—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.00212	0.00216	CcSEcCtD
Propericiazine—Hypotension—Vincristine—peripheral nervous system neoplasm	0.00211	0.00215	CcSEcCtD
Propericiazine—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.00209	0.00213	CcSEcCtD
Propericiazine—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.00209	0.00213	CcSEcCtD
Propericiazine—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.00208	0.00213	CcSEcCtD
Propericiazine—Increased appetite—Doxorubicin—peripheral nervous system neoplasm	0.00205	0.0021	CcSEcCtD
Propericiazine—Insomnia—Vincristine—peripheral nervous system neoplasm	0.00204	0.00208	CcSEcCtD
Propericiazine—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.002	0.00204	CcSEcCtD
Propericiazine—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.002	0.00204	CcSEcCtD
Propericiazine—Oedema—Cisplatin—peripheral nervous system neoplasm	0.002	0.00204	CcSEcCtD
Propericiazine—Infection—Cisplatin—peripheral nervous system neoplasm	0.00198	0.00202	CcSEcCtD
Propericiazine—Vomiting—Topotecan—peripheral nervous system neoplasm	0.00198	0.00202	CcSEcCtD
Propericiazine—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.00197	0.00201	CcSEcCtD
Propericiazine—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.00197	0.00201	CcSEcCtD
Propericiazine—Rash—Topotecan—peripheral nervous system neoplasm	0.00197	0.00201	CcSEcCtD
Propericiazine—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.00196	0.002	CcSEcCtD
Propericiazine—Rash—Isotretinoin—peripheral nervous system neoplasm	0.00195	0.00199	CcSEcCtD
Propericiazine—Rash—Tretinoin—peripheral nervous system neoplasm	0.00195	0.00199	CcSEcCtD
Propericiazine—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.00195	0.00199	CcSEcCtD
Propericiazine—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.00195	0.00199	CcSEcCtD
Propericiazine—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.00195	0.00199	CcSEcCtD
Propericiazine—Vomiting—Melphalan—peripheral nervous system neoplasm	0.00194	0.00198	CcSEcCtD
Propericiazine—Constipation—Vincristine—peripheral nervous system neoplasm	0.00193	0.00197	CcSEcCtD
Propericiazine—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.00193	0.00197	CcSEcCtD
Propericiazine—Rash—Melphalan—peripheral nervous system neoplasm	0.00192	0.00196	CcSEcCtD
Propericiazine—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.00192	0.00196	CcSEcCtD
Propericiazine—Hypokalaemia—Epirubicin—peripheral nervous system neoplasm	0.0019	0.00194	CcSEcCtD
Propericiazine—Domperidone—ABCB1—peripheral nervous system neoplasm	0.0019	0.0956	CrCbGaD
Propericiazine—Chlorpromazine—BCHE—peripheral nervous system neoplasm	0.00189	0.0953	CrCbGaD
Propericiazine—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.00187	0.0019	CcSEcCtD
Propericiazine—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.00186	0.0019	CcSEcCtD
Propericiazine—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.00185	0.00189	CcSEcCtD
Propericiazine—Nausea—Topotecan—peripheral nervous system neoplasm	0.00185	0.00189	CcSEcCtD
Propericiazine—Confusional state—Etoposide—peripheral nervous system neoplasm	0.00184	0.00188	CcSEcCtD
Propericiazine—Nausea—Tretinoin—peripheral nervous system neoplasm	0.00184	0.00187	CcSEcCtD
Propericiazine—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.00184	0.00187	CcSEcCtD
Propericiazine—Infection—Etoposide—peripheral nervous system neoplasm	0.00182	0.00185	CcSEcCtD
Propericiazine—Nausea—Melphalan—peripheral nervous system neoplasm	0.00181	0.00185	CcSEcCtD
Propericiazine—Asthma—Epirubicin—peripheral nervous system neoplasm	0.0018	0.00184	CcSEcCtD
Propericiazine—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.00179	0.00182	CcSEcCtD
Propericiazine—Eosinophilia—Epirubicin—peripheral nervous system neoplasm	0.00179	0.00182	CcSEcCtD
Propericiazine—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.00179	0.00182	CcSEcCtD
Propericiazine—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.00178	0.00182	CcSEcCtD
Propericiazine—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.00177	0.0018	CcSEcCtD
Propericiazine—Hypokalaemia—Doxorubicin—peripheral nervous system neoplasm	0.00176	0.00179	CcSEcCtD
Propericiazine—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.00173	0.00176	CcSEcCtD
Propericiazine—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.00173	0.00176	CcSEcCtD
Propericiazine—Hypotension—Etoposide—peripheral nervous system neoplasm	0.00171	0.00174	CcSEcCtD
Propericiazine—Asthma—Doxorubicin—peripheral nervous system neoplasm	0.00167	0.0017	CcSEcCtD
Propericiazine—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.00166	0.0017	CcSEcCtD
Propericiazine—Eosinophilia—Doxorubicin—peripheral nervous system neoplasm	0.00165	0.00169	CcSEcCtD
Propericiazine—Photosensitivity reaction—Epirubicin—peripheral nervous system neoplasm	0.00165	0.00168	CcSEcCtD
Propericiazine—Weight increased—Epirubicin—peripheral nervous system neoplasm	0.00164	0.00167	CcSEcCtD
Propericiazine—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.00163	0.00166	CcSEcCtD
Propericiazine—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	0.00163	0.00166	CcSEcCtD
Propericiazine—Somnolence—Etoposide—peripheral nervous system neoplasm	0.00163	0.00166	CcSEcCtD
Propericiazine—Pneumonia—Epirubicin—peripheral nervous system neoplasm	0.00162	0.00165	CcSEcCtD
Propericiazine—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.00161	0.00164	CcSEcCtD
Propericiazine—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.00161	0.00164	CcSEcCtD
Propericiazine—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.0016	0.00164	CcSEcCtD
Propericiazine—Rash—Dactinomycin—peripheral nervous system neoplasm	0.00159	0.00163	CcSEcCtD
Propericiazine—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.00158	0.00161	CcSEcCtD
Propericiazine—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.00157	0.0016	CcSEcCtD
Propericiazine—Constipation—Etoposide—peripheral nervous system neoplasm	0.00156	0.0016	CcSEcCtD
Propericiazine—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.00155	0.00158	CcSEcCtD
Propericiazine—Triflupromazine—ABCB1—peripheral nervous system neoplasm	0.00154	0.0774	CrCbGaD
Propericiazine—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	0.00152	0.00155	CcSEcCtD
Propericiazine—Weight increased—Doxorubicin—peripheral nervous system neoplasm	0.00152	0.00155	CcSEcCtD
Propericiazine—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.0015	0.00154	CcSEcCtD
Propericiazine—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.0015	0.00153	CcSEcCtD
Propericiazine—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.0015	0.00153	CcSEcCtD
Propericiazine—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	0.0015	0.00153	CcSEcCtD
Propericiazine—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.00149	0.00152	CcSEcCtD
Propericiazine—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.00149	0.00152	CcSEcCtD
Propericiazine—Rash—Alitretinoin—peripheral nervous system neoplasm	0.00148	0.00151	CcSEcCtD
Propericiazine—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.00148	0.00151	CcSEcCtD
Propericiazine—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.00147	0.0015	CcSEcCtD
Propericiazine—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.00145	0.00148	CcSEcCtD
Propericiazine—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.00145	0.00148	CcSEcCtD
Propericiazine—Vomiting—Vincristine—peripheral nervous system neoplasm	0.00144	0.00146	CcSEcCtD
Propericiazine—Rash—Vincristine—peripheral nervous system neoplasm	0.00142	0.00145	CcSEcCtD
Propericiazine—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.00142	0.00145	CcSEcCtD
Propericiazine—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.00139	0.00142	CcSEcCtD
Propericiazine—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	0.00139	0.00142	CcSEcCtD
Propericiazine—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.00137	0.00139	CcSEcCtD
Propericiazine—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.00135	0.00137	CcSEcCtD
Propericiazine—Nausea—Vincristine—peripheral nervous system neoplasm	0.00134	0.00137	CcSEcCtD
Propericiazine—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.00134	0.00137	CcSEcCtD
Propericiazine—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.00129	0.00132	CcSEcCtD
Propericiazine—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.00127	0.0013	CcSEcCtD
Propericiazine—Rash—Cisplatin—peripheral nervous system neoplasm	0.00126	0.00128	CcSEcCtD
Propericiazine—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.00126	0.00128	CcSEcCtD
Propericiazine—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.00125	0.00128	CcSEcCtD
Propericiazine—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.00124	0.00126	CcSEcCtD
Propericiazine—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.00119	0.00122	CcSEcCtD
Propericiazine—Nausea—Cisplatin—peripheral nervous system neoplasm	0.00119	0.00121	CcSEcCtD
Propericiazine—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.00118	0.00121	CcSEcCtD
Propericiazine—Fluphenazine—ABCB1—peripheral nervous system neoplasm	0.00118	0.0595	CrCbGaD
Propericiazine—Vomiting—Etoposide—peripheral nervous system neoplasm	0.00116	0.00119	CcSEcCtD
Propericiazine—Agitation—Epirubicin—peripheral nervous system neoplasm	0.00115	0.00118	CcSEcCtD
Propericiazine—Rash—Etoposide—peripheral nervous system neoplasm	0.00115	0.00118	CcSEcCtD
Propericiazine—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.00115	0.00118	CcSEcCtD
Propericiazine—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.0011	0.00112	CcSEcCtD
Propericiazine—Nausea—Etoposide—peripheral nervous system neoplasm	0.00109	0.00111	CcSEcCtD
Propericiazine—Clomipramine—ABCB1—peripheral nervous system neoplasm	0.00108	0.0544	CrCbGaD
Propericiazine—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.00107	0.00109	CcSEcCtD
Propericiazine—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.00105	0.00107	CcSEcCtD
Propericiazine—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.00103	0.00105	CcSEcCtD
Propericiazine—Oedema—Epirubicin—peripheral nervous system neoplasm	0.00103	0.00105	CcSEcCtD
Propericiazine—Infection—Epirubicin—peripheral nervous system neoplasm	0.00102	0.00104	CcSEcCtD
Propericiazine—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.001	0.00102	CcSEcCtD
Propericiazine—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000991	0.00101	CcSEcCtD
Propericiazine—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000968	0.000988	CcSEcCtD
Propericiazine—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000958	0.000978	CcSEcCtD
Propericiazine—Promethazine—ABCB1—peripheral nervous system neoplasm	0.000957	0.0482	CrCbGaD
Propericiazine—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000957	0.000976	CcSEcCtD
Propericiazine—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000949	0.000968	CcSEcCtD
Propericiazine—Trifluoperazine—ABCB1—peripheral nervous system neoplasm	0.000944	0.0476	CrCbGaD
Propericiazine—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000943	0.000962	CcSEcCtD
Propericiazine—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000927	0.000946	CcSEcCtD
Propericiazine—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000926	0.000945	CcSEcCtD
Propericiazine—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000917	0.000936	CcSEcCtD
Propericiazine—Quetiapine—ABCB1—peripheral nervous system neoplasm	0.000916	0.0461	CrCbGaD
Propericiazine—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000914	0.000933	CcSEcCtD
Propericiazine—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000912	0.00093	CcSEcCtD
Propericiazine—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000887	0.000904	CcSEcCtD
Propericiazine—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000877	0.000895	CcSEcCtD
Propericiazine—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000858	0.000875	CcSEcCtD
Propericiazine—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000846	0.000863	CcSEcCtD
Propericiazine—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000843	0.000861	CcSEcCtD
Propericiazine—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000811	0.000828	CcSEcCtD
Propericiazine—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000811	0.000827	CcSEcCtD
Propericiazine—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000755	0.000771	CcSEcCtD
Propericiazine—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.00075	0.000765	CcSEcCtD
Propericiazine—Chlorpromazine—ABCB1—peripheral nervous system neoplasm	0.000741	0.0373	CrCbGaD
Propericiazine—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000702	0.000716	CcSEcCtD
Propericiazine—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000699	0.000713	CcSEcCtD
Propericiazine—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000652	0.000665	CcSEcCtD
Propericiazine—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000649	0.000662	CcSEcCtD
Propericiazine—Rash—Epirubicin—peripheral nervous system neoplasm	0.000647	0.00066	CcSEcCtD
Propericiazine—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000646	0.000659	CcSEcCtD
Propericiazine—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000609	0.000621	CcSEcCtD
Propericiazine—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000603	0.000615	CcSEcCtD
Propericiazine—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000598	0.00061	CcSEcCtD
Propericiazine—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000598	0.00061	CcSEcCtD
Propericiazine—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000564	0.000575	CcSEcCtD
